# Sequential Letrozole and Methotrexate Therapy Role in Treatment of Tubal Ectopic Pregnancy

> **NCT06426979** · NA · COMPLETED · sponsor: **Zagazig University** · enrollment: 200 (actual)

## Conditions studied

- Pregnancy Tubal

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT06426979
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06426979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06426979, "Sequential Letrozole and Methotrexate Therapy Role in Treatment of Tubal Ectopic Pregnancy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06426979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*